These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 38881505)

  • 1. Environmental exposures, the oral-lung axis and respiratory health: The airway microbiome goes on stage for the personalized management of human lung function.
    Garmendia J; Cebollero-Rivas P
    Microb Biotechnol; 2024 Jun; 17(6):e14506. PubMed ID: 38881505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
    Raftery AL; Tsantikos E; Harris NL; Hibbs ML
    Front Immunol; 2020; 11():2144. PubMed ID: 33042125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of oral microbiome in respiratory health and diseases.
    Pathak JL; Yan Y; Zhang Q; Wang L; Ge L
    Respir Med; 2021; 185():106475. PubMed ID: 34049183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of pulmonary microorganisms in the development of chronic obstructive pulmonary disease.
    Liu J; Ran Z; Wang F; Xin C; Xiong B; Song Z
    Crit Rev Microbiol; 2021 Feb; 47(1):1-12. PubMed ID: 33040638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysbiosis of lower respiratory tract microbiome are associated with inflammation and microbial function variety.
    Li KJ; Chen ZL; Huang Y; Zhang R; Luan XQ; Lei TT; Chen L
    Respir Res; 2019 Dec; 20(1):272. PubMed ID: 31796027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The alterations of oral, airway and intestine microbiota in chronic obstructive pulmonary disease: a systematic review and meta-analysis.
    Kou Z; Liu K; Qiao Z; Wang Y; Li Y; Li Y; Yu X; Han W
    Front Immunol; 2024; 15():1407439. PubMed ID: 38779669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The airway microbiome mediates the interaction between environmental exposure and respiratory health in humans.
    Lin L; Yi X; Liu H; Meng R; Li S; Liu X; Yang J; Xu Y; Li C; Wang Y; Xiao N; Li H; Liu Z; Xiang Z; Shu W; Guan WJ; Zheng XY; Sun J; Wang Z
    Nat Med; 2023 Jul; 29(7):1750-1759. PubMed ID: 37349537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking and microbiome in oral, airway, gut and some systemic diseases.
    Huang C; Shi G
    J Transl Med; 2019 Jul; 17(1):225. PubMed ID: 31307469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Airway host-microbiome interactions in chronic obstructive pulmonary disease.
    Wang Z; Maschera B; Lea S; Kolsum U; Michalovich D; Van Horn S; Traini C; Brown JR; Hessel EM; Singh D
    Respir Res; 2019 Jun; 20(1):113. PubMed ID: 31170986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in Oral Microbiota in HIV Are Related to Decreased Pulmonary Function.
    Yang L; Dunlap DG; Qin S; Fitch A; Li K; Koch CD; Nouraie M; DeSensi R; Ho KS; Martinson JJ; Methé B; Morris A
    Am J Respir Crit Care Med; 2020 Feb; 201(4):445-457. PubMed ID: 31682463
    [No Abstract]   [Full Text] [Related]  

  • 11. Bacterial microbiome of lungs in COPD.
    Sze MA; Hogg JC; Sin DD
    Int J Chron Obstruct Pulmon Dis; 2014; 9():229-38. PubMed ID: 24591822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Oral-Lung Microbiome Axis in Connective Tissue Disease-Related Interstitial Lung Disease.
    Bongers KS; Massett A; O'Dwyer DN
    Semin Respir Crit Care Med; 2024 Jun; 45(3):449-458. PubMed ID: 38626906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the lung microbiota and the gut-lung axis in respiratory infectious diseases.
    Dumas A; Bernard L; Poquet Y; Lugo-Villarino G; Neyrolles O
    Cell Microbiol; 2018 Dec; 20(12):e12966. PubMed ID: 30329198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower Airway Dysbiosis Augments Lung Inflammatory Injury in Mild-to-Moderate Chronic Obstructive Pulmonary Disease.
    Sulaiman I; Wu BG; Chung M; Isaacs B; Tsay JJ; Holub M; Barnett CR; Kwok B; Kugler MC; Natalini JG; Singh S; Li Y; Schluger R; Carpenito J; Collazo D; Perez L; Kyeremateng Y; Chang M; Campbell CD; Hansbro PM; Oppenheimer BW; Berger KI; Goldring RM; Koralov SB; Weiden MD; Xiao R; D'Armiento J; Clemente JC; Ghedin E; Segal LN
    Am J Respir Crit Care Med; 2023 Nov; 208(10):1101-1114. PubMed ID: 37677136
    [No Abstract]   [Full Text] [Related]  

  • 15. The lung microbiome and exacerbations of COPD.
    Dy R; Sethi S
    Curr Opin Pulm Med; 2016 May; 22(3):196-202. PubMed ID: 26964078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lung microbiome in end-stage Lymphangioleiomyomatosis.
    Ng J; Pacheco-Rodriguez G; Begley L; Huang YJ; Poli S; Perrella MA; Rosas IO; Moss J; El-Chemaly S
    Respir Res; 2021 Oct; 22(1):277. PubMed ID: 34702264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiome: A Supportive or a Leading Actor in Lung Cancer?
    Martins D; Mendes F; Schmitt F
    Pathobiology; 2021; 88(2):198-207. PubMed ID: 33352574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic obstructive pulmonary disease upper airway microbiome is associated with select clinical characteristics.
    Pragman AA; Knutson KA; Gould TJ; Hodgson SW; Isaacson RE; Reilly CS; Wendt CH
    PLoS One; 2019; 14(7):e0219962. PubMed ID: 31335912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cigarette smoke-induced dysbiosis: comparative analysis of lung and intestinal microbiomes in COPD mice and patients.
    Laiman V; Chuang HC; Lo YC; Yuan TH; Chen YY; Heriyanto DS; Yuliani FS; Chung KF; Chang JH
    Respir Res; 2024 May; 25(1):204. PubMed ID: 38730440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosstalk between the lung microbiome and lung cancer.
    Meng Y; Mao Y; Tang Z; Qiu X; Bajinka O; Tan Y; Song Z
    Microb Pathog; 2023 May; 178():106062. PubMed ID: 36914054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.